Is DXCM a good stock to buy? We came across a bullish thesis on DexCom, Inc. on Part-Time Compounder’s Substack by Francesco Ferrari. In this article, we will summarize the bulls’ thesis on DXCM. DexCom, Inc.'s share was trading at $64.62 as of April 20th. DXCM’s trailing and forward P/E were 30.92 and 25.91, respectively according to Yahoo Finance.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.